SVB Leerink analyst Mani Foroohar maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lowers the price target from $66 to $64.
CFTC Slams HSBC With $75M Penalty For Unethical Practices, Claims Involvement Of Senior Leadership
HSBC Holdings PLC (NYSE: HSBC) has agreed to pay $75 million in penalty charges as ordered by U.S. Commodity Futures Trading Commission (CFTC).